Company news

Irhythm Holdings, Inc. (NASDAQ:IRTC) news

Irhythm Holdings, Inc. news releases on 6ix. Latest, Oct 5, 2026: IRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform…

View Irhythm Holdings, Inc. →

Press releases & updates

IRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care

October 5, 2026

IRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026

October 2, 2026

iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026

October 1, 2026

IRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference

August 26, 2026

IRhythm Holdings Announces Second Quarter 2026 Financial Results

August 6, 2026

IRhythm to Acquire VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care

August 6, 2026

IRhythm Holdings to Report Second Quarter 2026 Financial Results on August 6, 2026

July 16, 2026

iRhythm Holdings to Participate in Upcoming Investor Conferences

May 18, 2026

iRhythm Holdings Announces First Quarter 2026 Financial Results

April 30, 2026

iRhythm Holdings to Present at the Bank of America Securities 2026 Health Care Conference

April 28, 2026

iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026

April 16, 2026

Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform

March 29, 2026

iRhythm Holdings Appoints Jason Patten to its Board of Directors

March 12, 2026

iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results

February 19, 2026

iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

February 5, 2026

iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference

January 12, 2026

iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference

December 28, 2025

New Data at the Asia Pacific Heart Rhythm Society (APHRS) 2025 Highlight the Performance of iRhythm’s Zio Long-Term Continuous Monitoring in an Asian Population

November 20, 2025

iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025

November 10, 2025

iRhythm Technologies to Participate in Upcoming Investor Conferences

November 3, 2025

iRhythm Technologies Announces Third Quarter 2025 Financial Results

October 29, 2025

iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025

October 15, 2025

AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies’ Zio LTCM Service

August 28, 2025

AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm’s Zio LTCM Clinical Superiority

August 17, 2025

iRhythm Technologies Announces Second Quarter 2025 Financial Results

July 30, 2025

iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions

July 30, 2025

iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025

July 16, 2025

Integer Appoints Michael Coyle to Board of Directors

July 10, 2025

iRhythm Technologies Announces Board Member Retirements and New Director Appointments

July 6, 2025

New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease

June 23, 2025

iRhythm Technologies Announces First Quarter 2025 Financial Results

April 30, 2025

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

April 30, 2025

iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

April 28, 2025

iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring

April 27, 2025

iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025

April 16, 2025

iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability

April 15, 2025

iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection

March 30, 2025

iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results

February 19, 2025

iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

February 5, 2025

iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference

January 12, 2025

iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

December 29, 2024

iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference

November 19, 2024

iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring

November 17, 2024

iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference

November 4, 2024

iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device

October 29, 2024

iRhythm Technologies Announces Third Quarter 2024 Financial Results

October 29, 2024

Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy

October 27, 2024

iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device

October 20, 2024

iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024

October 15, 2024

iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence

September 10, 2024

Older →